Peripheral biological activity of SR 27897: a new potent non-peptide antagonist of CCKA receptors
- 23 February 1993
- journal article
- research article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 232 (1), 13-19
- https://doi.org/10.1016/0014-2999(93)90722-t
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cholecystokinin-dopamine intearctionsTrends in Pharmacological Sciences, 1991
- Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.JCI Insight, 1989
- ROLE OF CHOLECYSTOKININ IN REGULATION OF GASTROINTESTINAL MOTOR FUNCTIONSThe Lancet, 1989
- Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivoAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1989
- A new simple mouse model for the in vivo evaluation of cholecystokinin (CCK) antagonists: Comparative potencies and durations of action of nonpeptide antagonistsLife Sciences, 1986
- Identification and Characterization of a Specific Receptor for Cholecystokinin on Isolated Fundic Glands from Guinea Pig Gastric Mucosa Using a Biologically Active125I-CCK-8 ProbeJournal of Receptor Research, 1983
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980
- A new and rapid method for the clinical determination of α-amylase activities in human serum and urine. optimal conditionsClinica Chimica Acta; International Journal of Clinical Chemistry, 1969
- Cholecystokinin and Pancreozymin, one single Hormone?Acta Physiologica Scandinavica, 1966
- SOME QUANTITATIVE USES OF DRUG ANTAGONISTSBritish Journal of Pharmacology and Chemotherapy, 1959